Back to top

Neuroimmunology: research

In order to provide our patients with the best care and most innovative treatment, the Neuroimmunology Unit takes part in clinical trials that professionals believe may benefit our patients through the Clinical Research Unit.

We work together as part of the of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) neuroimmunology group in basic and translational research, which we conduct in laboratories managed by the Institute. Our aim is to find new diagnostic, prognostic and therapeutic tools to respond to inflammatory and autoimmune diseases.

We are currently leading several clinical and basic research studies on these types of disease. The following studies, in which more than 40 hospitals are taking part, are currently in progress:

  • Study of autoimmunity in herpetic encephalitis. National multicentre analysis in paediatric and adult patients with herpes simplex encephalitis. Coordinated by IDIBAPS, funded by the Mutua Madrileña Foundation.
  • Study on synaptic autoimmunity as a cause of psychosis, epilepsy and post-herpes encephalopathies in childhood. National multicentre research that includes all types of encephalitis in children. Coordinated by IDIBAPS, funded by the Spanish Paediatrics Association (AEP).
  • Study of diagnostic and prognostic markers in multiple sclerosis and other demyelinating paediatric diseases. Coordinated by the Clínic Foundation in collaboration with the Multiple Sclerosis Centre of Catalonia (CEMCAT) and funded by TV3’s La Marató Foundation.